FDA approves Salix’s diarrhea drug for HIV/AIDS patients



Mon Dec 31, 2012 1:54pm EST


(Reuters) – U.S. health regulators authorized Salix Pharmaceuticals Ltd’s drug to provide diarrhea in HIV/AIDS patients on antiretroviral therapy, a multiple of medicines used to provide HIV infection.

Diarrhea is a common reason because HIV/AIDS patients pause or switch their antiretroviral therapies.

The drug, called Fulyzaq, is dictated to be used in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite.

Until now, there have been no therapies for HIV-associated diarrhea authorized by a U.S. Food and Drug Administration.

(Reporting By Debra Sherman; Editing by David Gregorio)

More on: Health Medicine Network